SAMSUNG BIOLOGICS CO.,LTD.
Exchange sourced- Local ticker
- 207940
- ISIN
- KR7207940008
- Exchange
- Korea Exchange (Stock Market), XKRX
- Primary market
- Korea
Figures as of 6 November 2026, 18:00 UTC. Refreshed weekly.
What we hold
Counted over 15 years, by bundle.
Counts are classified documents, not pages. A name with no filings in a bundle still shows the bundle, so an empty row is a fact about the company rather than a gap in coverage.
| Bundle | Documents held | Most recent |
|---|---|---|
| Core Financials & GovernanceAnnual and interim reports, financial statements, AGM and remuneration material | 378 | 3 Nov 2026Report on ownership status of specific securities, etc. for executives and major shareholders |
| Corporate EventsAnnouncements, results releases, corporate actions, director dealings | 873 | 5 Nov 2026[Correction of entry] Report of major facts (decision to transfer stocks and investment securities of other corporations) |
| Earnings IntelligenceEarnings call transcripts, results presentations, capital markets days | 197 | 21 Oct 2026Q3 2026- Presenation |
| Sustainability & PoliciesSustainability reports, transition plans, supplier and human rights policies | 14 | 12 Jun 2026Samsung Biologics 2026 Engagement Report |
| MiscellaneousEverything the taxonomy places outside the four bundles above | 174 | 4 Nov 2026Paid-in capital increase new stock issuance price (information disclosure) |
| All bundles | 1,548 |
Most recent documents
The ten most recent, newest first. Every document carries the date it was published, the classification we assigned, and its length.
The full record for SAMSUNG BIOLOGICS CO.,LTD., every document in it and the whole archive behind it, is in Orbit Insight. Opening a document costs one credit and trial accounts start with 500.
| Document | Bundle | Published | Pages | Open |
|---|---|---|---|---|
| [Correction of entry] Report of major facts (decision to transfer stocks and investment securities of other corporations)Company Fact Sheet | Events | 5 Nov 2026 | 6 | Open in Insight |
| [Correction of entry] Decision to acquire stocks and investment securities of other corporations (major management matters of subsidiary companies)Regulatory Disclosure | Events | 5 Nov 2026 | 3 | Open in Insight |
| Paid-in capital increase new stock issuance price (information disclosure)Miscellaneous | Other | 4 Nov 2026 | 2 | Not yet openable |
| Company Fact Sheet | Events | 4 Nov 2026 | — | Not yet openable |
| [Correction to entry] Investment prospectusMiscellaneous | Other | 4 Nov 2026 | 511 | Not yet openable |
| [Confirmation of issuance conditions] Securities report (equity securities)Miscellaneous | Other | 4 Nov 2026 | 21 | Not yet openable |
| Report on ownership status of specific securities, etc. for executives and major shareholdersMajority Shareholder/Substantial Holding | Financials | 3 Nov 2026 | 4 | Open in Insight |
| Single sales and supply contract concludedRegulatory Disclosure | Events | 2 Nov 2026 | 1 | Open in Insight |
| [Correction of entry] Single sales and supply contract concludedRegulatory Disclosure | Events | 1 Nov 2026 | 2 | Open in Insight |
| Report on changes in shares owned by the largest shareholder, etc.Regulatory Disclosure | Events | 1 Nov 2026 | 2 | Open in Insight |
How it reaches you. And how fast.
The same facts are attached to every name in the universe, which is what makes a coverage answer checkable rather than a claim.
Open the full Korea coverage detail for the exchanges behind that company count, what the year’s volume is made of, and how the median latency is distributed.
Follow SAMSUNG BIOLOGICS CO.,LTD. and the rest of your universe.
Paste every name you hold into Orbit Insight and get this view for all of them, plus the documents themselves. Trial accounts start with 500 credits.
Missing a filing for KR7207940008?
If a document you expect for this name is not held, tell us which one and we will assess a backfill.